215 related articles for article (PubMed ID: 29754528)
1. Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
Vender R; Gooderham MJ; Guenther LC; Kyritsis D; Rao J; Kowalczyk A; Ashkenas J
J Cutan Med Surg; 2018; 22(5):464-471. PubMed ID: 29754528
[TBL] [Abstract][Full Text] [Related]
2. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
[TBL] [Abstract][Full Text] [Related]
3. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
[TBL] [Abstract][Full Text] [Related]
4. [From evidence to expertise: concordance in the topical management of psoriasis].
Jurado-Santa Cruz F; Páez-Agraz F
Rev Med Inst Mex Seguro Soc; 2016; 54(3):304-11. PubMed ID: 27100975
[TBL] [Abstract][Full Text] [Related]
5. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
Neri L; Miracapillo A
G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
Gual A; Pau-Charles I; Molin S
J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
[TBL] [Abstract][Full Text] [Related]
7. New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care.
Feldman SR; Fleischer AB; Cooper JZ
Int J Dermatol; 2000 Jan; 39(1):41-4. PubMed ID: 10651966
[TBL] [Abstract][Full Text] [Related]
8. [Adherence of local (and general) treatments in psoriasis].
Cribier B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
[TBL] [Abstract][Full Text] [Related]
9. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.
Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR
Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969
[TBL] [Abstract][Full Text] [Related]
10. Optimizing topical therapies for treating psoriasis: a consensus conference.
Zeichner JA; Lebwohl MG; Menter A; Bagel J; Del Rosso JQ; Elewski BE; Feldman SR; Kircik LH; Koo J; Gold LS; Tanghetti E;
Cutis; 2010 Sep; 86(3 Suppl):5-31; quiz 32. PubMed ID: 21049712
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis treatment in the United States at the end of the 20th century.
Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
[TBL] [Abstract][Full Text] [Related]
12. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for attributes of topical anti-psoriatic medicines.
Vasconcelos V; Teixeira A; Almeida V; Teixeira M; Ramos S; Torres T; Sousa Lobo JM; Almeida IF
J Dermatolog Treat; 2019 Nov; 30(7):659-663. PubMed ID: 30470146
[No Abstract] [Full Text] [Related]
14. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients.
Saeki H; Imafuku S; Abe M; Shintani Y; Onozuka D; Hagihara A; Katoh N; Murota H; Takeuchi S; Sugaya M; Tanioka M; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M
J Dermatol; 2015 Apr; 42(4):367-72. PubMed ID: 25720544
[TBL] [Abstract][Full Text] [Related]
15. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
Caldarola G; De Simone C; Moretta G; Poscia A; Peris K
J Dermatolog Treat; 2017 Dec; 28(8):722-725. PubMed ID: 28488449
[TBL] [Abstract][Full Text] [Related]
16. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.
Hong CH; Papp KA; Lophaven KW; Skallerup P; Philipp S
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1876-1883. PubMed ID: 28796913
[TBL] [Abstract][Full Text] [Related]
17. Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy.
Imafuku S; Zheng M; Tada Y; Zhang X; Theng C; Thevarajah S; Zhao Y; Song HJ
J Dermatol; 2018 Jul; 45(7):805-811. PubMed ID: 29740870
[TBL] [Abstract][Full Text] [Related]
18. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
Zschocke I; Mrowietz U; Karakasili E; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
[TBL] [Abstract][Full Text] [Related]
19. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.
Thorneloe RJ; Bundy C; Griffiths CE; Ashcroft DM; Cordingley L
Br J Dermatol; 2017 Mar; 176(3):667-676. PubMed ID: 27664406
[TBL] [Abstract][Full Text] [Related]
20. Patient Preferences in Topical Psoriasis Treatment.
Curcio A; Kontzias C; Gorodokin B; Feldman S; Kircik L
J Drugs Dermatol; 2023 Apr; 22(4):326-332. PubMed ID: 37026884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
